PRICE T ROWE ASSOCIATES INC /MD/ - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 58 filers reported holding OVID THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$52
+30.0%
13,414
+10.7%
0.00%
Q2 2023$40
-43.7%
12,113
-56.0%
0.00%
Q1 2023$71
+39.2%
27,5000.0%0.00%
Q4 2022$51
-99.9%
27,5000.0%0.00%
Q3 2022$51,000
-23.9%
27,500
-11.7%
0.00%
Q2 2022$67,000
-43.7%
31,133
-18.0%
0.00%
Q1 2022$119,000
-2.5%
37,9610.0%0.00%
Q4 2021$122,000
-4.7%
37,9610.0%0.00%
Q3 2021$128,000
-13.5%
37,9610.0%0.00%
Q2 2021$148,0000.0%37,961
+3.3%
0.00%
Q1 2021$148,000
-89.7%
36,748
-80.1%
0.00%
Q2 2018$1,442,000
-32.1%
184,811
-38.5%
0.00%
Q1 2018$2,124,000
-28.2%
300,480
+0.3%
0.00%
Q4 2017$2,957,000
-0.5%
299,570
-17.2%
0.00%
-100.0%
Q3 2017$2,971,000
-18.3%
361,6400.0%0.00%0.0%
Q2 2017$3,637,000361,6400.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders